Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ocugen, Inc. | 454,007 | reported | 03 Jan 2022 | tx 31+2,135,318−323,723 |
| Inozyme Pharma, Inc. | 0 | reported | 01 Jul 2025 | tx 15+703,201−538,201 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jul 2025 | TENDER | Inozyme Pharma, Inc. | 39,701 | 4.00 USD | |
| 01 Jul 2025 | OTHER | Inozyme Pharma, Inc. | 145,000 | — | deriv |
| 01 Jul 2025 | OTHER | Inozyme Pharma, Inc. | 135,000 | — | deriv |
| 01 Jul 2025 | OTHER | Inozyme Pharma, Inc. | 180,000 | — | deriv |
| 01 Jul 2025 | OTHER | Inozyme Pharma, Inc. | 38,500 | — | deriv |
| 25 Jun 2025 | GRANT_AWARD | Inozyme Pharma, Inc. | 6,813 | 0.74 USD | |
| 31 Mar 2025 | GRANT_AWARD | Inozyme Pharma, Inc. | 2,490 | 0.77 USD | |
| 11 Mar 2025 | GRANT_AWARD | Inozyme Pharma, Inc. | 145,000 | 0.00 USD | deriv |
| 11 Mar 2025 | GRANT_AWARD | Inozyme Pharma, Inc. | 38,500 | 0.00 USD | deriv |
| 13 Mar 2024 | GRANT_AWARD | Inozyme Pharma, Inc. | 165,000 | 0.00 USD | deriv |
| 29 Sept 2023 | GRANT_AWARD | Inozyme Pharma, Inc. | 2,319 | 3.57 USD | |
| 31 Mar 2023 | GRANT_AWARD | Inozyme Pharma, Inc. | 979 | 2.21 USD | |
| 23 Mar 2023 | GRANT_AWARD | Inozyme Pharma, Inc. | 135,000 | 0.00 USD | deriv |
| 19 Apr 2022 | PURCHASE | Inozyme Pharma, Inc. | 27,100 | 3.69 USD | first after silence |
| 21 Mar 2022 | GRANT_AWARD | Inozyme Pharma, Inc. | 180,000 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Ocugen, Inc. | 125,534 | 0.00 USD | |
| 03 Jan 2022 | GRANT_AWARD | Ocugen, Inc. | 454,007 | 0.00 USD | deriv |
| 16 Dec 2021 | GRANT_AWARD | Ocugen, Inc. | 35,560 | 0.00 USD | deriv |
| 16 Nov 2021 | GRANT_AWARD | Ocugen, Inc. | 35,560 | 0.00 USD | deriv |
| 26 Oct 2021 | SALE | Ocugen, Inc. | 10,000 | 11.07 USD | |
| 15 Oct 2021 | EXERCISE | Ocugen, Inc. | 7,990 | 2.19 USD | |
| 15 Oct 2021 | SALE | Ocugen, Inc. | 7,990 | 9.96 USD | |
| 15 Oct 2021 | EXERCISE | Ocugen, Inc. | 7,990 | 0.00 USD | deriv |
| 16 Aug 2021 | EXERCISE | Ocugen, Inc. | 30,000 | 0.34 USD | |
| 16 Aug 2021 | SALE | Ocugen, Inc. | 30,000 | 7.22 USD |
1 purchase reported after at least 12 months of silence — most recent on 19 Apr 2022.